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Advanced carotid disease is known to be associated with symptomatic cerebrovascular diseases, such as stroke or transient
ischemic attack (TIA), as well as with poststroke cognitive impairment. However, cognitive decline often occurs in patients with
advanced carotid stenosis without clinically evident stroke or TIA, so it is also suspected to be an independent risk factor for
dementia. Neurosonological methods enable simple and noninvasive assessment of carotid stenosis in patients at risk of advanced
atherosclerosis. Cognitive status in patients diagnosed with advanced carotid stenosis is routinely not taken into consideration,
although if cognitive impairment is present, such patients should probably be called symptomatic. In this paper, we discuss results
of some most important studies that investigated cognitive status of patients with asymptomatic advanced carotid disease and
possible mechanisms involved in the causal relationship between asymptomatic advanced carotid disease and cognitive decline.
1.Introduction
While detrimental eﬀects of stroke on cognitive functions
havebeenwelldocumentedintheliterature,themechanisms
linking advanced carotid disease and impaired cognitive sta-
tus in patients without symptomatic cerebrovascular inci-
dents are less clear.
Advanced carotid disease is associated with the presence
of multiple vascular risk factors, which most often include
arterial hypertension, dyslipidemia, cigarette smoking, dia-
betes, and older age [1–3] .T h es a m er i s kf a c t o r sw e r e
shown to be associated not only with vascular dementia,
but also with neurodegenerative dementia, importantly with
Alzheimer’s disease [4]. The vascular hypothesis of Alz-
heimer’s disease provides substantial evidence that vascular
riskfactorsplayacriticalroleinthedevelopmentofcognitive
impairment and clinically evident dementia during aging
[4]. Vascular dementia and Alzheimer’s disease in their
pure forms are two ends of a pathologic continuum [5].
However, many studies during the last decade implicated the
overlap of their pathologies. It was shown that a substantial
proportion of brains who meet neuropathological criteria
for Alzheimer’s disease also demonstrate lesions typical for
vascular pathology, such as cerebral amyloid angiopathy,
microvascular degeneration, and periventricular white mat-
ter lesions [6, 7]. Results of the seminal “Nun Study” that
followed 102 elderly nuns until postmortem showed higher
prevalence of clinically expressed dementia in those who
met neuropathological criteria for Alzheimer’s disease and
simultaneously had brain infarcts [8]. Furthermore, in a
3-year follow-up study of stroke patients who were not
demented before the stroke, one-third of the patients who
developed poststroke dementia were diagnosed as suﬀering
from Alzheimer’s disease [9]. There is now substantial and
growing evidence from studies of epidemiology, pharmacol-
ogy, neuroimaging, clinical medicine, microscopic anatomy,
and cellular-molecular biology to hypothesize that sporadic
Alzheimer’s disease is induced or accelerated by impaired
cerebral perfusion [10–14].
There are few proposed mechanisms aiming to explain
the link between carotid stenosis and cognitive impairment.
Carotid stenosis itself could directly cause decreased cog-
nitive functioning or it may act as a marker of cerebral
atherosclerosis due to the presence of conventional vascular
risk factors in such patients [15]. Preexistent silent cerebral
ischemia, lacunar infarcts, or preclinical Alzheimer’s disease2 Stroke Research and Treatment
in patients with carotid stenosis may also inﬂuence their
neuropsychological performance.
According to population studies, carotid disease of
v a r i o u sd e g r e ec a nb ef o u n di nm o r et h a n7 5 %o fm e na n d
in more than 62% of women older than 65 years of age.
Total prevalence of carotid disease over 50% in the same age
g r o u pi s7 %i nm e na n d5 %i nw o m e n[ 16]. Repercussions
of carotid stenosis/occlusion on intracranial hemodynamics
have been recognised by Spencer and Reid [17]. According
to their study and the known “Spencer curve,” in mild and
moderate carotid stenosis brain blood perfusion remains
stable, until high-grade carotid stenosis occurs [18]. Besides
cerebralmicroembolisation, proposed mechanisms of cogni-
tive impairment in individuals with advanced carotid disease
thus include chronic hypoperfusion.
During normal aging process, cerebral blood ﬂow mod-
estly diminishes and can decrease up to 20% by the age of
65 [19, 20]. Aging is often accompanied by increase in minor
memory problems which are followed by more pronounced
cognitiveimpairment[21,22].Sincecognitivedeclineduring
aging is commonly prodromal to Alzheimer’s disease or to
vasculardementia(VaD),treatingdiseaseharbingers,suchas
cerebrovascular and cardiovascular risk factors, may be one
of the most important prevention strategies aimed at either
dementia [14]. Mild, diﬀuse brain damage related to chronic
hypoperfusion may aﬀect the brain’s ability to process
information quickly and eﬃciently even in the absence
of discrete white matter lesions [23]. Not surprisingly,
carotid stenosis in asymptomatic individuals can produce a
reduction of subtle cognitive abilities involving the function
of the hemisphere ipsilateral to the carotid stenosis [4].
Despite the possible poor cognitive outcome, in the
absence of stroke or TIA, patients diagnosed with advanced
carotid disease are considered asymptomatic and their
cognitivestatusisnotroutinelyassessed.Decreasedcognitive
functioning in those patients so far has not been recognised
as possible factor that could inﬂuence therapeutic decision
related to the carotid disease.
2.Assessment of CognitiveFunctioningin
Patientswith CarotidStenosis
An u m b e ro fp r e v i o u ss t u d i e ss u g g e s t e dt h a ti ns t r o k e / T I A -
free patients severe carotid disease might be associated with
subtle cognitive changes, but results of studies have not
been consistent [3, 16, 24–26]. The principal reasons for
somewhat conﬂicting results are diﬀerences in study designs,
mostly small sample size, and nonconsistent selection of
cognitive tests performed. Only few studies of cognitive
status,mostlyonasmallnumberofpatients,wereconducted
in patients with advanced carotid disease [3, 16, 25]. Patients
with carotid disease were shown to have signiﬁcantly worse
scores on cognitive tests than matched controls. Cognitive
problems experienced by patients with advanced carotid
disease are mostly subtle and not severe enough to interfere
with their daily activities, therefore remaining unrecognized
by their closest family or friends [15]. Such changes are
insuﬃc i e n tt om e e tc r i t e r i af o rd e m e n t i aa n dt h e r e f o r e
correspond to mild cognitive impairment (MCI).
Although modern cognitive neuropsychology has devel-
oped sophisticated tests in order to assess the diﬀerent
cognitive functions, most studies of cognitive impairment in
patients with carotid disease used simple Mini-Mental-State
Examination (MMSE) as a routine cognitive measure [27].
Others used more extensive neuropsychological instruments
in order to analyze cognitive domains [16, 24].
The Mini-Mental State Examination (MMSE) remains
the most commonly applied screening test in clinical prac-
tice. It includes ﬁve cognitive domains (with a maximum
score of 30 points); however it does not contain much
capacity to test frontal/executive or visuospatial functions.
Another problem with MMSE is its low sensitivity in
detecting subtle, early-phase cognitive changes so it is not
recommended for screening for MCI [28, 29]. Patients
with discrete decline of cognitive status (such as patients
with carotid disease) often ﬁnd tasks involved in MMSE
insultingly simple.
Neuropsychological testing with standardized cognitive
tests is time consuming and diﬃcult to implement in
busy clinical settings; therefore some more recent studies
of cognitive functioning in patients with carotid disease
successfully used Montreal Cognitive Assessment (MoCA)
as a simple and brief screening tool with high sensitivity
for subtle cognitive impairment [29–31]. The MoCA is a
30-point test involving eight cognitive domains in which
results below cut-oﬀ score indicate cognitive impairment. A
workshop group of NIH and Canadian Stroke Consortium
proposed the selected MoCA subtests, including a 5-word
immediate and delayed memory test, a 6-item orientation
task, and a 1-letter phonemic ﬂuency test (the letter F), for
a routine use in a ﬁve-minute protocol aiming to assess
individuals with possible vascular cognitive impairment
[32].
Due to the lack of inclusion of frontal lobe tests in
commonly applied MMSE, it appears that MoCA could be
recommendedasmoreappropriatetoolfortheassessmentof
cognitive changes in patients with carotid stenosis. Although
the aim of routinely used screening tests is to detect the pres-
ence of cognitive impairment and not to distinguish between
its causes, patients with predominantly vascular etiology of
subtle cognitive impairment and probable signiﬁcant frontal
lobe pathology could be tested more accurately using MoCA
as it contains both subtests with executive function and with
memory.
Despite the growing number of studies that have investi-
gated cognitive impairment in patients with carotid disease,
correct pathophysiological interpretation of the underlying
mechanisms remains unclear. The relationship of decreased
cognitive status and asymptomatic carotid stenosis was
published from the observations from the Tromsø study,
including results from a heterogeneous group of patients
with bilateral carotid stenosis of ≥35% [3]. Their perfor-
mances in a battery of extensive neuropsychological tests
were compared with results from subjects without carotid
stenoses. In this study, patients with carotid disease achieved
signiﬁcantly lower levels of performance in several subsets
of cognitive tests. In a large number of 4006 asymptomatic
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and diagnosed with various degrees of carotid stenosis,
Johnston et al. used the modiﬁed MMSE in order to
evaluate the cognitive status [16]. This study found that
advanced stenosis (≥75%) of the left internal carotid artery
was associated with a cognitive impairment and cognitive
decline during the followup, but no signiﬁcant correlation
was detected for right-sided stenoses. As the correlation of a
left carotid stenosis and reduced cognitive functioning was
observed even in participants without evidence of cerebral
infarction on MRI, it is likely that an asymptomatic carotid
stenosis may be an independent risk factor for a cognitive
impairment. In our pilot study, as well as in a study
performed on a larger number of 70 patients diagnosed
with advanced carotid stenosis or occlusion, we have shown
cognitive impairment detectable by MoCA, but not by
MMSE [30, 31]. MoCA subtests analysis in patients with
carotid disease demonstrated signiﬁcantly lower subscores
in multiple domains, including visuospatial and executive
functions, attention, and delayed recall [31]. Similar results
were achieved in the Tromsø study where patients with
asymptomatic carotid stenosis scored worse at attention,
memory, psychomotor speed, and motor functioning [3].
However, comparing of studies results presents a major
problem due to diﬀerences in cognitive testing methods.
Silvestrini et al. reported on reduced cognitive scores at
verbal ﬂuency in patients with severe left-sided ICA stenosis
while those with right-sided stenosis performed worse at
abstract reasoning and executive functions [33]. This is
similar to the results from Bossema et al. [34]. According
to Komulainen et al. the degree of carotid artery stenosis
correlates with the extent of cognitive loss [35]. In the
Framingham Oﬀspring study, in a followup of subgroup of
1971 participants with carotid disease, carotid disease was
found to be associated with signiﬁcant poorer performance
on cognitive tests in asymptomatic subjects without signs of
silent cerebral infarcts or white matter hyperintensities on
brain MRI [36]. Study that included Canadian First Nations
population who have a larger proportions of vascular risk
factors showed contradictory results as individuals with
left-sided carotid disease were less likely to have cognitive
impairment. However, cognitive measurements were per-
formed using only the “Trial Making Test” and only the
small proportion of patients included were diagnosed with
advanced carotid disease [37].
3. Conclusions
The eﬀect of carotid stenosis on cognitive functioning
remainsfarfrombeingunambiguouslyexplained.Systematic
and carefully designed prospective studies with deﬁned and
consecutive inclusion of patients screened for concomitant
disorders that might inﬂuence cognitive functioning, the use
of uniformed neuropsychological testing, and appropriate
neuroimaging (MRI) assessment in patients with carotid
disease are still lacking. However, despite diﬀerences in stud-
ies results, we believe that asymptomatic advanced carotid
stenosis should be considered an independent risk factor
for the decline in cognitive functioning. If asymptomatic
advanced carotid stenosis causes cognitive impairment, the
threshold for operative treatment may change and reduction
inriskforcognitiveimpairmentmaybeanimportantbeneﬁt
of interventions to treat carotid disease [15]. For the time
being, eﬀective treatment of vascular risk factors remains
themostimportantclinicalrecommendationforstroke/TIA-
free patients with carotid stenosis. As cognitive problems in
stroke/TIA-free patients with carotid disease are so far often
underestimated in routine clinical practice, the use of MoCA
could aid in better recognition of this problem.
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